IMMX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Immix Biopharma Inc (IMMX).


$60.52M Market Cap.

As of 03/25/2025 5:00 PM ET (MRY) • Disclaimer

IMMX Market Cap. (MRY)


IMMX Shares Outstanding (MRY)


IMMX Assets (MRY)


Total Assets

$22.95M

Total Liabilities

$9.70M

Total Investments

$0

IMMX Income (MRY)


Revenue

$0

Net Income

-$21.61M

Operating Expense

$22.67M

IMMX Cash Flow (MRY)


CF Operations

-$14.60M

CF Investing

-$1.18M

CF Financing

$15.95M

IMMX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

-

0%

-

IMMX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$22,947,872 (15.17%)

$19,925,160 (33.65%)

$14,908,101 (-18.05%)

$18,192,088 (3271.42%)

Assets Current

$20,197,834 (2.07%)

$19,787,750 (32.82%)

$14,897,817 (-18.08%)

$18,186,393 (3316.98%)

Assets Non-Current

$2,750,038 (1901.34%)

$137,410 (1236.15%)

$10,284 (80.58%)

$5,695 (-22.63%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$13,251,203 (-19.23%)

$16,405,114 (24.66%)

$13,159,805 (-26.85%)

$17,990,049 (480.29%)

Property Plant & Equipment Net

$2,729,620 (5339.55%)

$50,181 (1309.58%)

$3,560 (-37.49%)

$5,695 (-22.63%)

Cash & Equivalents

$17,681,954 (0.98%)

$17,509,791 (30.31%)

$13,436,714 (-23.85%)

$17,644,478 (4411.66%)

Accumulated Other Comprehensive Income

-$1,056 (-100.78%)

$134,666 (54.75%)

$87,021 (-30.61%)

$125,408 (-4.89%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$8,621,899 (131.66%)

$3,721,783 (192.30%)

$1,273,296 (790.79%)

$142,940 (-43.36%)

Accumulated Retained Earnings (Deficit)

-$75,024,671 (-40.47%)

-$53,411,295 (-40.61%)

-$37,985,247 (-27.66%)

-$29,755,534 (-453.94%)

Tax Assets

$1,974,370 (68.44%)

$1,172,183 (358.41%)

$255,705 (894.11%)

$25,722 (-79.82%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$1,074,770 (0%)

$0 (0%)

$0 (0%)

$50,000 (-98.78%)

Debt Current

$65,219 (0%)

$0 (0%)

$0 (0%)

$50,000 (-98.78%)

Debt Non-Current

$1,009,551 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Liabilities

$9,696,669 (160.54%)

$3,721,783 (112.88%)

$1,748,296 (765.33%)

$202,039 (-96.17%)

Liabilities Current

$8,687,118 (133.41%)

$3,721,783 (192.30%)

$1,273,296 (530.22%)

$202,039 (-96.17%)

Liabilities Non-Current

$1,009,551 (0%)

$0 (0%)

$475,000 (0%)

$0 (0%)

IMMX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$11,381,978 (53.68%)

$7,406,082 (84.09%)

$4,023,170 (228.29%)

$1,225,487 (495.76%)

Research & Development Expense

$11,292,702 (29.28%)

$8,735,031 (108.19%)

$4,195,778 (3216.11%)

$126,527 (-49.01%)

Operating Expenses

$22,674,680 (40.48%)

$16,141,113 (96.39%)

$8,218,948 (507.90%)

$1,352,014 (197.90%)

Interest Expense

$0 (0%)

$0 (0%)

$497 (-99.72%)

$179,853 (76.37%)

Income Tax Expense

$41,037 (55.35%)

$26,415 (157.26%)

$10,268 (70.76%)

$6,013 (-65.73%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$21,698,363 (-39.13%)

-$15,595,522 (-89.50%)

-$8,229,713 (66.25%)

-$24,383,879 (-2024.28%)

Net Income to Non-Controlling Interests

-$84,987 (49.85%)

-$169,474 (0%)

$0 (0%)

$0 (0%)

Net Income

-$21,613,376 (-40.11%)

-$15,426,048 (-87.44%)

-$8,229,713 (66.25%)

-$24,383,879 (-2024.28%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$21,613,376 (-40.11%)

-$15,426,048 (-87.44%)

-$8,229,713 (66.25%)

-$24,383,879 (-2024.28%)

Weighted Average Shares

$28,285,637 (63.11%)

$17,341,146 (24.87%)

$13,887,309 (278.13%)

$3,672,611 (8.82%)

Weighted Average Shares Diluted

$28,285,637 (63.11%)

$17,341,146 (24.87%)

$13,887,309 (278.13%)

$3,672,611 (8.82%)

Earning Before Interest & Taxes (EBIT)

-$21,572,339 (-40.08%)

-$15,399,633 (-87.37%)

-$8,218,948 (66.03%)

-$24,198,013 (-2253.11%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$22,674,680 (-40.48%)

-$16,141,113 (-96.39%)

-$8,218,948 (-507.90%)

-$1,352,014 (-197.90%)

IMMX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$1,177,680 (-2160.90%)

-$52,089 (0%)

$0 (0%)

-$802 (0%)

Net Cash Flow from Financing

$15,948,567 (3.14%)

$15,463,512 (378.44%)

$3,232,063 (-82.85%)

$18,848,934 (0%)

Net Cash Flow from Operations

-$14,595,102 (-28.35%)

-$11,371,438 (-53.50%)

-$7,408,303 (-366.13%)

-$1,589,307 (-292.72%)

Net Cash Flow / Change in Cash & Cash Equivalents

$172,163 (-95.77%)

$4,073,077 (196.80%)

-$4,207,764 (-124.39%)

$17,253,392 (5131.20%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$1,177,680 (-2160.90%)

-$52,089 (0%)

$0 (0%)

-$802 (0%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

-$50,000 (-125.00%)

$200,000 (0%)

Issuance (Purchase) of Equity Shares

$15,948,567 (2.74%)

$15,523,128 (451.68%)

$2,813,787 (-84.91%)

$18,648,934 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$3,622 (-110.95%)

$33,092 (204.97%)

-$31,524 (-480.23%)

-$5,433 (-108.80%)

Share Based Compensation

$3,020,573 (17.73%)

$2,565,708 (389.57%)

$524,069 (139.32%)

$218,983 (0%)

Depreciation Amortization & Accretion

$115,388 (2010.24%)

$5,468 (156.11%)

$2,135 (-13.49%)

$2,468 (6.33%)

IMMX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-104.70% (-3.77%)

-100.90% (-107.61%)

-48.60% (86.79%)

-367.80% (-1442.34%)

Return on Average Assets (ROAA)

-77.70% (10.38%)

-86.70% (-88.07%)

-46.10% (82.29%)

-260.30% (-68.04%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-59867.00% (-534.48%)

13779.00% (259.42%)

-8643.40% (-211.82%)

7729.80% (4792.28%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-2.9 (62.77%)

-7.78 (-100.33%)

-3.88 (-624.07%)

-0.54

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

4.57 (-45.50%)

8.38 (245.71%)

2.42 (70.11%)

1.43

Debt to Equity Ratio (D/E)

0.73 (222.47%)

0.23 (70.68%)

0.13 (1109.09%)

0.01 (100.99%)

Earnings Per Share (EPS)

-0.76 (14.61%)

-0.89 (-50.85%)

-0.59 (91.11%)

-6.64 (-1852.94%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-0.56 (15.33%)

-0.66 (-23.64%)

-0.53 (-23.09%)

-0.43 (-260.83%)

Book Value Per Share (BVPS)

0.47 (-50.53%)

0.95 (-0.21%)

0.95 (-80.65%)

4.9 (449.36%)

Tangible Assets Book Value Per Share (TABVPS)

0.81 (-29.42%)

1.15 (6.98%)

1.07 (-78.32%)

4.95 (2995.63%)

Enterprise Value Over EBIT (EV/EBIT)

-2 (75.00%)

-8 (-300.00%)

-2 (-100.00%)

-1

Enterprise Value Over EBITDA (EV/EBITDA)

-1.95 (74.50%)

-7.66 (-320.13%)

-1.82 (-47.85%)

-1.23

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

2.33 (-56.27%)

5.32 (-54.56%)

11.7 (-87.00%)

90.01 (89022.77%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$15,772,782 (-38.07%)

-$11,423,527 (-54.20%)

-$7,408,303 (-365.90%)

-$1,590,109 (-292.92%)

Enterprise Value (EV)

$41,915,425 (-64.45%)

$117,898,765 (687.23%)

$14,976,462 (-49.81%)

$29,840,940

Earnings Before Tax (EBT)

-$21,572,339 (-40.08%)

-$15,399,633 (-87.36%)

-$8,219,445 (66.28%)

-$24,377,866 (-2056.73%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$21,456,951 (-39.38%)

-$15,394,165 (-87.35%)

-$8,216,813 (66.04%)

-$24,195,545 (-2258.20%)

Invested Capital

-$2,346,430 (-79.61%)

-$1,306,414 (-759.50%)

$198,091 (-49.92%)

$395,571 (138.72%)

Working Capital

$11,510,716 (-28.35%)

$16,065,967 (17.92%)

$13,624,521 (-24.24%)

$17,984,354 (479.58%)

Tangible Asset Value

$22,947,872 (15.17%)

$19,925,160 (33.65%)

$14,908,101 (-18.05%)

$18,192,088 (3271.42%)

Market Capitalization

$60,516,801 (-55.98%)

$137,481,190 (331.07%)

$31,892,983 (24.43%)

$25,632,000

Average Equity

$20,652,070 (35.03%)

$15,294,324 (-9.60%)

$16,917,907 (155.18%)

$6,629,732 (258.29%)

Average Assets

$27,818,240 (56.33%)

$17,794,473 (-0.32%)

$17,852,169 (90.61%)

$9,365,842 (1163.49%)

Invested Capital Average

$36,034 (132.24%)

-$111,762 (-217.53%)

$95,090 (130.38%)

-$313,050 (51.91%)

Shares

27,507,637 (38.46%)

19,867,224 (42.65%)

13,927,067 (93.43%)

7,200,000 (0.00%)